Stockscreener 앱 받기
89.34
1.00%
-0.90
시간 외 거래:
89.34
전일 마감가:
$90.24
열려 있는:
$89.61
하루 거래량:
6.51M
Relative Volume:
0.86
시가총액:
$114.47B
수익:
$33.54B
순이익/손실:
$4.66B
주가수익비율:
24.68
EPS:
3.62
순현금흐름:
$5.19B
1주 성능:
-3.87%
1개월 성능:
+0.66%
6개월 성능:
-1.63%
1년 성능:
+11.00%
1일 변동 폭
$88.69
$89.96
1주일 범위
$88.69
$92.75
52주 변동 폭
$79.29
$96.25
메드트로닉 Stock (MDT) Company Profile
명칭
Medtronic Plc
전화
01135314381700
주소
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
MDT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
메드트로닉 Stock (MDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-10-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 재확인 | Oppenheimer | Perform |
| 2024-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2024-08-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | 다운그레이드 | UBS | Buy → Sell |
| 2023-01-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-11-23 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-11-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-08-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-06-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-10 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-12-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | 업그레이드 | Stifel | Hold → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-05-14 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2020-03-30 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2020-03-25 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Sell |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-02 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-06-05 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-27 | 재확인 | Argus | Buy |
모두보기
메드트로닉 주식(MDT)의 최신 뉴스
Orchestra BioMed secures $70 million from Ligand and Medtronic By Investing.com - Investing.com UK
What markets is GDRX expanding into Is Medtronic plc stock a good long term investment option - jammulinksnews.com
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewswire
$70M Strategic Investment Powers Orchestra BioMed's Revolutionary Leadless Pacemaker Technology - Stock Titan
What are the technical indicators suggesting about Medtronic plcLow Risk Recommendation With High Returns - jammulinksnews.com
What is Medtronic plc company’s growth strategyChart Pattern Growth Plan For Every Investor - jammulinksnews.com
Diabetes Care Devices Market Size Projects USD 76.44 Billion by 2034 - GlobeNewswire Inc.
Medtronic: Growth Challenges Persist (NYSE:MDT) - Seeking Alpha
Why Is Medtronic Exiting Diabetes? - Medical Device and Diagnostic industry
Will Medtronic Bring the Renal Denervation Market to the Forefront? - Medical Device and Diagnostic industry
What the charts say about Medtronic plc todayDaily Smart Money Movement Monitor Activated - metal.it
Bollinger Bands Show Potential Breakout in Medtronic plcLow Risk Equity Screener With Results Shared - metal.it
Mizuho Lifts PT on Medtronic (MDT) to $100 From $98, Keeps an Outperform Rating - MSN
Why Medtronic (MDT) is One of the Most Trusted Safe Dividend Stocks in Healthcare - Yahoo Finance
What are Medtronic plc company’s key revenue driversFinancial News Target Finder For Smart Trading - jammulinksnews.com
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know - Nasdaq
Why is Medtronic plc stock attracting strong analyst attentionRetirement Planning Review With Proven Results - jammulinksnews.com
Medtronic shares snapped six-session winning streak (NYSE:MDT) - Seeking Alpha
What are analysts’ price targets for Medtronic plc in the next 12 monthsAI Powered Growth Plan From AI Tools - jammulinksnews.com
Is it the right time to buy Medtronic plc stockUnlock powerful investment tools for free - jammulinksnews.com
When is Medtronic plc stock expected to show significant growthAchieve fast wealth growth with smart picks - jammulinksnews.com
How does Medtronic plc generate profit in a changing economyGrow your portfolio with growth-oriented stocks - jammulinksnews.com
How many analysts rate Medtronic plc as a “Buy”Dynamic investment growth - jammulinksnews.com
What institutional investors are buying Medtronic plc stockPhenomenal returns - jammulinksnews.com
Published on: 2025-07-28 01:52:57 - jammulinksnews.com
Should I hold or sell Medtronic plc stock in 2025Build a winning portfolio with smart picks - jammulinksnews.com
How does Medtronic plc compare to its industry peersBreakout stock performance - jammulinksnews.com
What makes Medtronic plc stock price move sharplyElite Investor Club - Metal.it
Medtronic plc (MDT): A Bull Case Theory - MSN
What analysts say about Medtronic plc stockHigh-yield trading alerts - PrintWeekIndia
Medtronic takes next step to submit bone graft for new FDA indication - MassDevice
Telemetric Devices Market Set to Witness Significant Growth - openPR.com
Here's What to Expect From Medtronic's Next Earnings Report - MSN
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott - Yahoo Finance
Medtronic's Fiscal Q1 2026 Earnings Preview: What to ExpectNews and Statistics - IndexBox
Here's What To Expect From Medtronic's Next Earnings Report - Barchart.com
Medtronic receives Type 2 label expansion for MiniMed 780G in Europe - MedTech Dive
Medtronic plc (NYSE:MDT) is largely controlled by institutional shareholders who own 87% of the company - simplywall.st
Insulin Pumps Market Outlook Report 2025, with Leading Player Profiles for Medtronic, Insulet, Tandem Diabetes Care, and More - uk.finance.yahoo.com
What drives Medtronic plc stock priceDynamic profit opportunities - Autocar Professional
Medtronic plc Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional
Is Medtronic plc a good long term investmentMarket-crushing profits - jammulinksnews.com
메드트로닉 (MDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.80%
0.47%
자본화:
|
볼륨(24시간):